1840
Most of the clinical data on the safety profile of desmopressin (DDAVP), which is an effective treatment for both polyuric conditions and bleeding disorders, originate from studies on the tailoring of drug treatment, whereas few reports exist describing severe side effects secondary to drug-drug interaction.
 ( potential therapeutic event: treatment ,  both polyuric conditions and bleeding disorders: Subject, desmopressin (DDAVP): Treatment, desmopressin: Treatment.Drug, polyuric conditions: Treatment.Disorder, bleeding disorders: Treatment.Disorder) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( potential therapeutic event: treatment ,  both polyuric conditions and bleeding disorders: Subject, desmopressin (DDAVP): Treatment, desmopressin: Treatment.Drug, polyuric conditions: Treatment.Disorder, bleeding disorders: Treatment.Disorder) 